Juillerat, P

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 9.

Journal Article

Juillerat, P; Schneeweiss, S; Cook, E F; Ananthakrishnan, A N; Mogun, H; Korzenik, J R (2012). Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Alimentary pharmacology & therapeutics, 36(3), pp. 239-47. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2012.05173.x

Juillerat, P; Wasan, SK; Fowler, SA; Yajnik, V; Korzenik, JR; Pabby, VK; Friedman, S; Coukos, JA; Barto, AE; Pellish, R; and Farraye, FA (2012). Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 5 Academic Hospitals. Journal of Crohn's & Colitis, 6(Supplement 1), p. 128. Amsterdam: Elsevier

Juillerat, P (2012). Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. ECCO news, 7(1) Wien: European Crohn's and Colitis Organisation ECCO

Pittet, V; Juillerat, P; Michetti, P; Vader, J-P; Burnand, B; Rogler, G; Beglinger, C; Seibold, F; Mottet, C; Felley, C; Gonvers, J-J; Froehlich, F; Swiss Cohort Study, (2010). Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Alimentary pharmacology & therapeutics, 32(8), pp. 1007-16. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04434.x

Camara, RJ; Juillerat, P; Pittet, V; Schoepfer, AM; Begré, S; von Känel, R (2010). Psychological stress predicting adverse events in Cohn's disease. Psychosomatic medicine, 2010(72), A34. Baltimore, Md.: Lippincott Williams & Wilkins

Camara, RJ; Juillerat, P; Pittet, V; Schoepfer, AM; Begré, S; von Känel, R (2010). Quality of life predicting adverse events in Crohn's disease. Psychosomatic medicine, 2010(72), A34. Baltimore, Md.: Lippincott Williams & Wilkins

Pittet, V; Juillerat, P; Mottet, C; Felley, C; Ballabeni, P; Burnand, B; Michetti, P; Vader, JP; and, the Swiss IBD Cohort Study Group (2009). Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). International journal of epidemiology, 38(4), pp. 922-31. Oxford: Oxford University Press 10.1093/ije/dyn180

Conference or Workshop Item

Juillerat, P; Schneeweiss, S; Mogun, H; Cook, EF; Ananthakrishnan, AN; Korzenik, JR (2011). New H2-eceptor Antagonist Use May Increase Risk of Surgery or Hospitalization in Crohn's Disease While PPI Use May Be Associated With Ulcerative Colitis Flares. Differential Effects of Acid Suppressing Agents in IBD. In: Digestive Disease Week.

Juillerat, P; Schneeweiss, S; Cook, F; Ananthakrishnan, A; Mogun, H; Korzenik, J (2011). Gastric Acid Inhibiting Medications May Alter The Course Of Inflammatory Bowel Disease. In: 19th United European Gastroenterology Week (UEGW). Stockholm, Sweden. October 22-26, 2011.

This list was generated on Mon Aug 19 01:12:39 2019 CEST.
Provide Feedback